Summary:
Bio-Rad Laboratories has expanded its Droplet Digital PCR (ddPCR) product portfolio with four new platforms, including the QX Continuum and QX700 series, enhancing its capabilities in genomics research and diagnostics.

Takeaways:

  1. Expanded Portfolio: The launch adds to Bio-Rad’s existing QX200 and QX600 systems, offering the most comprehensive suite of ddPCR tools with over 400,000 assays.
  2. Broad Application Range: The new systems are tailored for diverse applications such as oncology, infectious disease, genetic research, environmental testing, and biopharma QC.
  3. Advanced Features: The QX Continuum offers qPCR-like workflows and four-color multiplexing, while the QX700 series supports seven-color multiplexing, high-throughput processing, and continuous sample loading.

Bio-Rad Laboratories, Inc., a global provider in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum ddPCR system along with the QX700 series of ddPCR platforms acquired as part of the company’s recently completed acquisition of digital PCR developer Stilla Technologies.

End-to-End Solutions

Together with Bio-Rad’s existing line of QX200 and QX600 ddPCR systems, the expanded product portfolio, including over 400,000 assays, offers the most comprehensive line of digital PCR products for life science research and diagnostic applications. The end-to-end solutions feature industry-leading absolute quantification, high precision, and advanced multiplexing capabilities, combined with streamlined and simplified workflows.

“With this launch, our expanded portfolio of instruments, reagents, software, and services extends Bio-Rad’s presence in the genomics research and applied science markets and strengthens our leadership in droplet digital PCR solutions,” says Jim Barry, EVP and president of Bio-Rad’s Life Science Group. “The newly introduced platforms complement Bio-Rad’s existing QX ddPCR portfolio and offer our customers unparalleled workflow simplicity and throughput capabilities across the full spectrum of digital PCR applications including oncology, infectious disease, and genetic research.”

ddPCR Systems Designed for Multiple Applications

The QX Continuum ddPCR system is designed for translational research applications. It features qPCR-like workflow offering simplicity, performance and flexibility in an all-in-one configuration with four-color multiplexing and up to eight discrete thermal profiles per plate. 

The QX700 series consists of three new ddPCR instruments designed for academic research, environmental testing, cell and gene therapy, and biopharma quality control workflows. The systems enable seven-color multiplexing, capacity to process over 700 samples per day, with minimal input volume, continuous loading capability, and easy-to-use software for streamlined data interpretation.

BIO-RAD, QX CONTINUUM, QX700, QX600, QX200, DROPLET DIGITAL, and DDPCR are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions.

Featured Image: Dirk Van Geel | Dreamstime.com